Fellowship · Santa Monica, CA
Sponsored by Saint John's Cancer Institute
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Lancet (London, England) · 2024 · 686 citations · Mark Faries
Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma.
The New England journal of medicine · 2024 · 254 citations · Walavan Sivakumar
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 795 citations · Dana Omer
Multiple early factors anticipate post-acute COVID-19 sequelae.
Cell · 2022 · 907 citations · Trevan Fischer
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine · 2023 · 739 citations · Gary Deutsch, Kim Margolin
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 304 citations ·
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
The New England journal of medicine · 2024 · 438 citations · Mark Faries
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 269 citations · Kim Margolin